Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Josep Ramon Germà"'
Autor:
Francesc Viñals, Alberto Villanueva, Gabriel Capellà, Josep Ramon Germà, Josefina Mora, Oriol Casanovas, Enric Condom, August Vidal, Xavier Garcia del Muro, Josep Maria Piulats, Wilmar Castillo-Ávila
Purpose: Germ cell tumors (GCT) of the testis are highly curable, but those patients who are refractory to cisplatin (CDDP)-based combination chemotherapy have a poor prognosis. Therefore, identifying new alternatives for treatment remains a priority
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29ae3139c77aa0f3986fb7abc63fb575
https://doi.org/10.1158/1078-0432.c.6517257.v1
https://doi.org/10.1158/1078-0432.c.6517257.v1
Autor:
Francesc Viñals, Alberto Villanueva, Gabriel Capellà, Josep Ramon Germà, Josefina Mora, Oriol Casanovas, Enric Condom, August Vidal, Xavier Garcia del Muro, Josep Maria Piulats, Wilmar Castillo-Ávila
Supplementary Data from Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::003db4d30bdb4a22ba1a24156c90fd57
https://doi.org/10.1158/1078-0432.22439853.v1
https://doi.org/10.1158/1078-0432.22439853.v1
Autor:
Gabriel Capellá, Helena Aguilar, Josep Ramon Germà-Lluch, Mitch Dowsett, Lesley-Ann Martin, Ander Urruticoechea, Xavier Solé
Publikováno v:
Breast Cancer Research and Treatment. 109:463-470
Introduction Changes in breast cancer cell biology following hormonal treatment have been claimed as promising predictor markers of clinical benefit even outperforming clinical response. From previous work we selected 10 genes showing both a well kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c89a003f562c2cdee4109a5ad615355
https://doi.org/10.1007/s10549-007-9676-7
https://doi.org/10.1007/s10549-007-9676-7
Autor:
Josep Ramon Germà, Cati Falo, Francisco Javier Pérez-Martin, Anna Petit, María Jesús Pla, Fina Climent, Adela Fernandez-Otega, Carlos Mesia, Amparo Garcia-Tejedor, Miguel Gil-Gil, Sonia Pernas, María Ochoa de Olza, A Guma, Ana López-Ojeda, Ander Urruticoechea
Publikováno v:
Breast cancer research and treatment. 134(3)
One of the most efficacious primary therapies in HER2-positive breast cancer was published by the M.D. Anderson group in 2005. This randomized trial evaluated the addition of trastuzumab to a taxane-anthracycline based chemotherapy. Despite largely s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0d4192a3f9e85f524de48b9919dd31
https://pubmed.ncbi.nlm.nih.gov/22772380
https://pubmed.ncbi.nlm.nih.gov/22772380
Publikováno v:
Revista espanola de geriatria y gerontologia. 45(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::31bbab7105e018f73fb30a2dfd0acace
https://pubmed.ncbi.nlm.nih.gov/20399538
https://pubmed.ncbi.nlm.nih.gov/20399538
Publikováno v:
Medicina clinica. 129(4)
To assess the impact on the medicines budget of the introduction of new treatments in colorectal cancer, as monoclonal antibodies cetuximab and bevacizumab and oxaliplatin in the adjuvant setting, for the Catalan health public system in 2006.In advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5fe98fe269b86948465872187f4a3da8
https://pubmed.ncbi.nlm.nih.gov/18457627
https://pubmed.ncbi.nlm.nih.gov/18457627
Autor:
Gemma, Tarafa, Esther, Prat, Rosa-Ana, Risques, Sara, González, Jordi, Camps, Mónica, Grau, Elisabeth, Guinó, Víctor, Moreno, Manel, Esteller, James G, Herman, Josep-Ramon, Germà, Rosa, Miró, Miguel Angel, Peinado, Gabriel, Capellá
Publikováno v:
Cancer research. 63(18)
Cancer cells progress through the accumulation of genetic alterations. Familial adenomatous polyposis (FAP) tumors provide an excellent model to unravel the molecular steps underlying malignant transformation. Global genomic damage was assessed in 56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::03a6ae1ef7b2579a0b79764450ac72e8
https://pubmed.ncbi.nlm.nih.gov/14522893
https://pubmed.ncbi.nlm.nih.gov/14522893
Autor:
Josep Ramon Germà Lluch
Publikováno v:
Medicina Clínica. 135:598-599
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a4cce65364ce24f2f4a4670d8170f94
https://doi.org/10.1016/j.medcli.2010.03.017
https://doi.org/10.1016/j.medcli.2010.03.017
Publikováno v:
Revista Española de Geriatría y Gerontología. 45:121-122
Juana Saldana Canada a, , Antonio Yuste Marco b y Josep Ramon Germ a Lluch c a Servicio de Oncologia Medica, Hospital Duran i Reynals, Institut Catal a d’Oncologia, L’Hospitalet de Llobregat, Barcelona, Espana b Direccion de Geriatria, Direccion
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba515af23282e03406a73ceeddcfce61
https://doi.org/10.1016/j.regg.2010.02.004
https://doi.org/10.1016/j.regg.2010.02.004